HomeQuestion
Would you ever consider foregoing surveillance CT scans for resected stage II or III colon cancer in favor of circulating ctDNA assays?
1 Answers
Mednet Member
Medical Oncology
As someone who was introduced to CEA in colon surveillance when discovered simultaneously by Gold and LoGerfo in the early 1970s, I am excited by the rapid acceptance of ctDNA in evaluation and management of colon cancer. We know that ctDNA can be positive up to 9 months before a CT scan demonstrate...